Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Peridialysis BP levels and risk of all-cause mortality: a dose-response meta-analysis

Abstract

Blood pressure (BP) management posed great challenge in hemodialysis (HD) population. We conducted a dose-response meta-analysis to investigate the quantitative features and the potential threshold effect of the associations between peridialysis BP levels and all-cause mortality risk in HD population. We searched all of the prospective cohort studies (published before 18 March 2017) on the associations between peridialysis BP levels and all-cause mortality risk. A total of 229,688 prevalent HD patients from 8 studies were included. Significant non-linear associations were noted between peridialytic BP levels and all-cause mortality risk. Significant increased risk of death was found in four peridialysis BP ranges, that is, low levels of predialysis SBP (<135 mmHg, 140 mmHg as the reference), two extremes of predialysis DBP (<55 and >95 mmHg, 90 mmHg as the reference), high levels of postdialysis SBP (>180 mmHg, 130 mmHg as the reference), and low levels of postdialysis DBP (<75 mmHg, 80 mmHg as the reference). Threshold effect was determined in the associations between peridialysis BP and all-cause mortality risk, and potential BP thresholds were identified (149 mmHg for predialysis SBP, 79 mmHg for predialysis DBP, 147 mmHg for postdialysis SBP and 76 mmHg for postdialysis DBP). In conclusion, the proposed peridialysis BP ranges and the threshold values could help clinicians identify high risk HD patients. The interpretation of the peridialysis BP mortality associations should be based on the features of HD population (especially the cardiovascular conditions, volume status and the dialysis vintage).

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, et al. “U” curve association of blood pressure and mortality in hemodialysis patients. Kidney Int. 1998;54:561–9.

    Article  CAS  PubMed  Google Scholar 

  2. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, et al. Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis. 1999;33:507–17.

    Article  CAS  PubMed  Google Scholar 

  3. Kalantar-Zadeh K, Kilpatrick RD, McAllister CJ, Greenland S, Kopple JD. Reverse epidemiology of hypertension and cardiovascular death in the hemodialysis population: the 58th annual fall conference and scientific sessions. Hypertension . 2005;45:811–7.

    Article  CAS  PubMed  Google Scholar 

  4. Stidley CA, Hunt WC, Tentori F, Schmidt D, Rohrscheib M, Paine S, et al. Changing relationship of blood pressure with mortality over time among hemodialysis patients. J Am Soc Nephrol. 2006;17:513–20.

    Article  PubMed  Google Scholar 

  5. Myers OB, Adams C, Rohrscheib MR, Servilla KS, Miskulin D, Bedrick EJ, et al. Age, race, diabetes, blood pressure, and mortality among hemodialysis patients. J Am Soc Nephrol. 2010;21:1970–8.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bansal N, McCulloch CE, Rahman M, Kusek JW, Anderson AH, Xie D, et al. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study. Hypertension. 2015;65:93–100.

    Article  CAS  PubMed  Google Scholar 

  7. Shafi T, Zager PG, Sozio SM, Grams ME, Jaar BG, Christenson RH, et al. Troponin I and NT-proBNP and the association of systolic blood pressure with outcomes in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis. 2014;64:443–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Agarwal R. Hypertension and survival in chronic hemodialysis patients—past lessons and future opportunities. Kidney Int. 2005;67:1–13.

    Article  PubMed  Google Scholar 

  9. Chang TI. Systolic blood pressure and mortality in patients on hemodialysis. Curr Hypertens Rep. 2011;13:362–9.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Khan YH, Sarriff A, Adnan AS, Khan AH, Mallhi TH. Blood pressure and mortality in hemodialysis patients: a systematic review of an ongoing debate. Ther Apher Dial. 2016;20:453–61.

    Article  PubMed  Google Scholar 

  11. Georgianos PI, Agarwal R. Blood pressure and mortality in long-term hemodialysis-time to move forward. Am J Hypertens. 2017;30:211–22.

    CAS  PubMed  Google Scholar 

  12. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283:2008–12.

    Article  CAS  PubMed  Google Scholar 

  13. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 10 Mar 2017.

  14. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992;135:1301–9.

    Article  CAS  PubMed  Google Scholar 

  15. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175:66–73.

    Article  PubMed  Google Scholar 

  16. Desquilbet L, Mariotti F. Dose-response analyses using restricted cubic spline functions in public health research. Stat Med. 2010;29:1037–57.

    PubMed  Google Scholar 

  17. Aune D, Saugstad OD, Henriksen T, Tonstad S. Maternal body mass index and the risk of fetal death, stillbirth, and infant death: a systematic review and meta-analysis. JAMA. 2014;311:1536–46.

    Article  CAS  PubMed  Google Scholar 

  18. Wang X, Ouyang Y, Liu J, Zhu M, Zhao G, Bao W, et al. Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ. 2014;349:g4490.

    Article  PubMed  PubMed Central  Google Scholar 

  19. K/DOQI Workgroup. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis. 2005;45:S1–153.

    Google Scholar 

  20. Bekkering GE, Harris RJ, Thomas S, Mayer AM, Beynon R, Ness AR, et al. How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis? Am J Epidemiol. 2008;167:1017–26.

    Article  PubMed  Google Scholar 

  21. Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic doseresponse data. Epidemiology. 1993;4:218–28.

    Article  CAS  PubMed  Google Scholar 

  22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Muggeo VM. Estimating regression models with unknown break-points. Stat Med. 2003;22:3055–71.

    Article  PubMed  Google Scholar 

  24. Muggeo VM. Segmented: an R package to fit regression models with broken-line relationships. R News. 2008;8:20–25.

    Google Scholar 

  25. Saran R, Bragg-Gresham JL, Rayner HC, Goodkin DA, Keen ML, Van Dijk PC, et al. Nonadherence in hemodialysis: associations with mortality, hospitalization, and practice patterns in the DOPPS. Kidney Int. 2003;64:254–62.

    Article  PubMed  Google Scholar 

  26. Agarwal R. Hypervolemia is associated with increased mortality among hemodialysis patients. Hypertension. 2010;56:512–7.

    Article  CAS  PubMed  Google Scholar 

  27. Chazot C, Wabel P, Chamney P, Moissl U, Wieskotten S, Wizemann V. Importance of normohydration for the long-term survival of haemodialysis patients. Nephrol Dial Transplant. 2012;27:2404–10.

    Article  PubMed  Google Scholar 

  28. Crippa A, Orsini N. Multivariate dose-response meta-analysis: the dosresmeta R package. J Stat Softw. 2016;72:1–15.

    Article  Google Scholar 

  29. Core Team RR: A language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2015.

  30. Foley RN, Herzog CA, Collins AJ. United States renal data system. Blood pressure and long-term mortality in United States hemodialysis patients: USRDS Waves 3 and 4 Study. Kidney Int. 2002;62:1784–90.

    Article  PubMed  Google Scholar 

  31. Li Z, Lacson E Jr, Lowrie EG, Ofsthun NJ, Kuhlmann MK, et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis. 2006;48:606–15.

    Article  PubMed  Google Scholar 

  32. Molnar MZ, Lukowsky LR, Streja E, Dukkipati R, Jing J, Nissenson AR, et al. Blood pressure and survival in longterm hemodialysis patients with and without polycystic kidney disease. J Hypertens. 2010;28:2475–84.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Chang TI, Friedman GD, Cheung AK, Greene T, Desai M, Chertow GM. Systolic blood pressure and mortality in prevalent haemodialysis patients in the HEMO study. J Hum Hypertens. 2011;25:98–105.

    Article  CAS  PubMed  Google Scholar 

  34. Robinson BM, Tong L, Zhang J, Wolfe RA, Goodkin DA, Greenwood RN, et al. Blood pressure levels and mortality risk among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study. Kidney Int. 2012;82:570–80.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Inaba M, Karaboyas A, Akiba T, Akizawa T, Saito A, Fukuhara S, et al. Association of blood pressure with all-cause mortality and stroke in Japanese hemodialysis patients: the Japan Dialysis Outcomes and Practice Pattern Study. Hemodial Int. 2014;18:607–15.

    Article  PubMed  Google Scholar 

  36. Foley RN. Cardiac disease in chronic uremia: can it explain the reverse epidemiology of hypertension and survival in dialysis patients? Semin Dial. 2004;17:275–8.

    Article  PubMed  Google Scholar 

  37. Agarwal R, Light R. Intradialytic hypertension is a marker of volume excess. Nephrol Dial Transplant. 2010;25:3355–61.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Hannedouche T, Roth H, Krummel T, London GM, Jean G, Bouchet JL, et al. Multiphasic effects of blood pressure on survival in hemodialysis patients. Kidney Int. 2016;90:674–84.

    Article  PubMed  Google Scholar 

  39. Wanner C, Amann K, Shoji T. The heart and vascular system in dialysis. Lancet. 2016;388:276–84.

    Article  PubMed  Google Scholar 

  40. Agarwal R, Sinha AD. Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis. Hypertension. 2009;53:860–6.

    Article  CAS  PubMed  Google Scholar 

  41. Heerspink HJ, Ninomiya T, Zoungas S, de Zeeuw D, Grobbee DE, Jardine MJ, et al. Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials. Lancet. 2009;373:1009–15.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Zoccali C, Moissl U, Chazot C, Mallamaci F, Tripepi G, Arkossy O, et al. Chronic Fluid Overload and Mortality in ESRD. J Am Soc Nephrol. 2017;28:2491–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Miskulin DC, Gassman J, Schrader R, Gul A, Jhamb M, Ploth DW, et al. BP in dialysis: results of a pilot study. J Am Soc Nephrol. 2018;29:307–16.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by grants to Bi-Cheng Liu from Clinic Research Center program of Jiangsu Province (BL2014080).

Code availability

The R code used to generate results can be accessed by contacting Yu-Chen Han (njhanyuchen@163.com).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bi-Cheng Liu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Han, YC., Tu, Y., Zhou, LT. et al. Peridialysis BP levels and risk of all-cause mortality: a dose-response meta-analysis. J Hum Hypertens 33, 41–49 (2019). https://doi.org/10.1038/s41371-018-0103-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41371-018-0103-9

This article is cited by

Search

Quick links